KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) Assets Average (2016 - 2025)

Historic Assets Average for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to $1.2 billion.

  • Fulgent Genetics' Assets Average fell 209.25% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 209.25%. This contributed to the annual value of $1.2 billion for FY2024, which is 633.59% down from last year.
  • Latest data reveals that Fulgent Genetics reported Assets Average of $1.2 billion as of Q3 2025, which was down 209.25% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Assets Average registered a high of $1.5 billion during Q2 2022, and its lowest value of $849.8 million during Q1 2021.
  • For the 5-year period, Fulgent Genetics' Assets Average averaged around $1.3 billion, with its median value being $1.2 billion (2024).
  • As far as peak fluctuations go, Fulgent Genetics' Assets Average soared by 100609.91% in 2021, and later plummeted by 1077.19% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Assets Average stood at $1.2 billion in 2021, then increased by 12.42% to $1.4 billion in 2022, then decreased by 7.1% to $1.3 billion in 2023, then fell by 5.4% to $1.2 billion in 2024, then decreased by 1.6% to $1.2 billion in 2025.
  • Its Assets Average stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.